Javascript must be enabled to continue!
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
View through CrossRef
Heparin binds to smooth muscle cells and endothelial cells. It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells. Fibroblasts which represent an other cell type belonging to the vascular wall could also have their growth modified by heparin. We have at first, demonstrated that 125I unfractionated heparin bigds to cultured human skin fibroblasts with a Kd of 1.16 10 M.A low molecular weight heparin fraction (PK 10169) competed (50 %)with I unfractionated heparin, but at aless extent than cold unfractionated heparin(90%).As it has been reported with endothelial and smooth muscle cells, about 30% of the bound unfractionated heparin was internalized bythe fibroblasts. Heparin alone at the concentration ranges from 0 to 10-5M has no effect on fibroblast proliferation measured by the H thymidine uptake. When the cellproliferation was induced by pure PDGF, heparin potentiated markedly the fibroblast growth.The effgct started at 10-8 M heparinand reached a plateau from 10-6 M to 10-5 M. Similar stimulationwas observed when the growth was induced by FGF or EGF. Low molecular weight heparin enhanced the fibroblast proliferation induced by PDGF but at a less extent than unfractionated heparin, chondroltin sulfate has no effect. When added during the cell culture growth withhuman serum (5%), unfractionated heparin increased by 48 the cell proliferation as measured bycell counting at the 6th day of the culture. PDGF did not modify the heparin binding on fibroblast cultures either at 4°C or 37°C and did not alter the process of heparin internalization. JDGF binding to the cultured fibroblast (Kd 10.1 ± 3.4 10-10 M)was not modified by the presence of heparin when studied at 4°C.In conclusion : i) cultured human fibroblasts bind and internalize heparin, ii) heparinand heparin fraction stimulate the fibroblastgrowth induced by PDGF, iii) since the binding of PDGF is not modified by bound heparin, the mechanism of stimulation remains unknown.
Title: HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
Description:
Heparin binds to smooth muscle cells and endothelial cells.
It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells.
Fibroblasts which represent an other cell type belonging to the vascular wall could also have their growth modified by heparin.
We have at first, demonstrated that 125I unfractionated heparin bigds to cultured human skin fibroblasts with a Kd of 1.
16 10 M.
A low molecular weight heparin fraction (PK 10169) competed (50 %)with I unfractionated heparin, but at aless extent than cold unfractionated heparin(90%).
As it has been reported with endothelial and smooth muscle cells, about 30% of the bound unfractionated heparin was internalized bythe fibroblasts.
Heparin alone at the concentration ranges from 0 to 10-5M has no effect on fibroblast proliferation measured by the H thymidine uptake.
When the cellproliferation was induced by pure PDGF, heparin potentiated markedly the fibroblast growth.
The effgct started at 10-8 M heparinand reached a plateau from 10-6 M to 10-5 M.
Similar stimulationwas observed when the growth was induced by FGF or EGF.
Low molecular weight heparin enhanced the fibroblast proliferation induced by PDGF but at a less extent than unfractionated heparin, chondroltin sulfate has no effect.
When added during the cell culture growth withhuman serum (5%), unfractionated heparin increased by 48 the cell proliferation as measured bycell counting at the 6th day of the culture.
PDGF did not modify the heparin binding on fibroblast cultures either at 4°C or 37°C and did not alter the process of heparin internalization.
JDGF binding to the cultured fibroblast (Kd 10.
1 ± 3.
4 10-10 M)was not modified by the presence of heparin when studied at 4°C.
In conclusion : i) cultured human fibroblasts bind and internalize heparin, ii) heparinand heparin fraction stimulate the fibroblastgrowth induced by PDGF, iii) since the binding of PDGF is not modified by bound heparin, the mechanism of stimulation remains unknown.
Related Results
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract
Introduction
Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
Abstract
Background: Essential Thrombocythemia (ET) is characterized by persistently elevated platelet counts in the context of a normal red cell mass. However, the ...
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rA...
GW24-e2369 Aliskiren inhibits proliferation of vascular smooth muscle cells induced by platelet-derived growth factor-BB via extracellular regulated protein kinases signal pathway
GW24-e2369 Aliskiren inhibits proliferation of vascular smooth muscle cells induced by platelet-derived growth factor-BB via extracellular regulated protein kinases signal pathway
Objectives
To identify the effect of direct renin inhibitor aliskiren on proliferation of vascular smooth muscle cells (VSMCs) induced by PDGF-BB, and study the m...
Repression of PDGF-R-α after cellular injury involves TNF-α, formation of a c-Fos-YY1 complex, and negative regulation by HDAC
Repression of PDGF-R-α after cellular injury involves TNF-α, formation of a c-Fos-YY1 complex, and negative regulation by HDAC
Wound healing is a complex dynamic process involving a variety of cell types, including fibroblasts that express and respond to cytokines and growth factors in the local microenvir...
Transforming growth factor-β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells
Transforming growth factor-β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells
Activated liver fat-storing cells (FSC) are known to play a key role in the development of liver fibrosis. An important element in FSC activation process is the increased expressio...
Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database
Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database
IntroductionLimited data are available on the use, duration, and dosage of anticoagulant therapy in patients with pneumonia-induced sepsis, and the survival benefits of heparin rem...
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Abstract
Abstract 2217
Introduction, aims of the study:
Cardiac surgery (CS) is associated with high risk of anti...

